Go Deep
Rallybio Corporation
Rallybio Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,691 | 2.1 | 0.95 | 0.00 | 1,605.09 |
| Oct 2026 | 21,735 | 2.1 | 0.94 | 0.00 | 1,592.97 |
| Oct 2026 | 21,901 | 2.0 | 0.92 | 0.00 | 1,541.96 |
| Oct 2026 | 21,879 | 2.0 | 0.92 | 0.00 | 1,550.25 |
| Oct 2026 | 21,869 | 2.0 | 0.92 | 0.00 | 1,553.09 |
| Oct 2026 | 21,919 | 2.0 | 0.91 | 0.00 | 1,534.12 |
| Oct 2026 | 21,867 | 2.0 | 0.92 | 0.00 | 1,548.01 |
Rallybio Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 212,000.0 | 222,000.0 | 212,000.0 |
| Net Profit | 43,665,000.0 | -8,278,000.0 | -5,852,000.0 | 16,016,000.0 |
| EPS | 7.7 | -1.5 | — | 2.9 |
Rallybio Corporation Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 858,000.0 | 636,000.0 | 0.0 | 0.0 | — |
| Net Profit | -8,978,000.0 | -57,775,000.0 | -74,564,000.0 | -66,654,000.0 | — |
| EPS | -1.6 | -10.6 | -14.7 | -16.7 | — |
Rallybio Corporation Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 62,261,000.0 | 68,108,000.0 | 115,620,000.0 | 180,435,000.0 | — |
| Total Liabilities | 4,305,000.0 | 6,454,000.0 | 9,436,000.0 | 11,118,000.0 | — |
| Total Equity | 57,956,000.0 | 61,654,000.0 | 106,184,000.0 | 169,317,000.0 | — |
Owes vs Owns
Rallybio Corporation owed $0.04 for every $1 it owned in Jun 2026, down from $0.06 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.04× | 0.07× | 0.09× | 0.08× | 0.06× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Rallybio Corporation Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 87.9%Other assets 11.8%
How it's funded — Dec 2025
Other liabilities 6.4%Shareholders' equity 93.1%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 54.7 | 65.5 | 109.9 | 169.0 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.2 | 0.3 | 0.6 | 0.9 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.2 | 0.0 |
| Other assets | 7.3 | 2.3 | 4.9 | 10.5 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 0.2 | 0.2 | 0.2 |
| Long-term debt | 0.1 | 0.0 | 0.2 | 0.4 |
| Payables | 0.1 | 0.3 | 1.0 | 1.1 |
| Other liabilities | 4.0 | 6.0 | 8.1 | 9.4 |
| Shareholders' equity | 58.0 | 61.7 | 106.2 | 169.3 |
| Net tangible assets | 58.0 | 61.7 | 106.2 | 169.3 |
Rallybio Corporation Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -29,813,000.0 | -49,282,000.0 | -60,265,000.0 | -57,284,000.0 | — |
| Investing Activities | 47,268,000.0 | 33,492,000.0 | 27,658,000.0 | -112,170,000.0 | — |
| Financing Activities | 16,000.0 | 5,199,000.0 | 143,000.0 | 51,078,000.0 | — |